EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Rhei Radix et Rhizoma and its anthraquinone derivatives: Potential candidates for pancreatitis treatment

Qi Qiu, Fei Fu, Yaling Wu, Chenxia Han, Weiling Pu, Li Wen, Qing Xia, Dan Du

Phytomedicine · 2024

DOI: 10.1016/j.phymed.2024.155708 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Phytomedicine, 2024. Verfasst von Qi Qiu und 7 weiteren Autor:innen. Beteiligte Einrichtung: West China Center of Excellence for Pancreatitis, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan Univ…. Hauptthemen laut MEDLINE: Anthraquinones, Rheum, Pancreatitis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 249 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pancreatitis is a common exocrine inflammatory disease of the pancreas and lacks specific medication currently. Rhei Radix et Rhizoma (RR) and its anthraquinone derivatives (AQs) have been successively reported for their pharmacological effects and molecular mechanisms in experimental and clinical pancreatitis. However, an overview of the anti-pancreatitis potential of RR and its AQs is limited. PURPOSE: To summarize and analyze the pharmacological effects of RR and its AQs on pancreatitis and the underlying mechanisms, and discuss their drug-like properties and future perspectives. METHODS: The articles related to RR and its AQs were collected from the Chinese National Knowledge Infrastructure, Wanfang data, PubMed, and the Web of Science using relevant keywords from the study's inception until April first, 2024. Studies involving RR or its AQs in cell or animal pancreatitis models as well as structure-activity relationship, pharmacokinetics, toxicology, and clinical trials were included. RESULTS: Most experimental studies are based on severe acute pancreatitis rat models and a few on chronic pancreatitis. Several bioactive anthraquinone derivatives of Rhei Radix et Rhizoma (RRAQs) exert local protective effects on the pancreas by maintaining pancreatic acinar cell homeostasis, inhibiting inflammatory signaling, and anti-fibrosis, and they improve systemic organ function by alleviating intestinal and lung injury. Pharmacokinetic and toxicity studies have revealed the low bioavailability and wide distribution of RRAQs, as well as hepatotoxicity and nephrotoxicity. However, there is insufficient research on the clinical application of RRAQs in pancreatitis. Furthermore, we propose effective strategies for subsequent improvement in terms of balancing effectiveness and safety. CONCLUSION: RRAQs can be developed as either candidate drugs or novel lead structures for pancreatitis treatment. The comprehensive review of RR and its AQs provides references for optimizing drugs, developing therapies, and conducting future studies on pancreatitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnthraquinonesRheumPancreatitisAnimalsHumansDrugs, Chinese HerbalRhizomePancreasStructure-Activity RelationshipRatsDisease Models, Animal

Stichwörter der Autor:innen

Anthraquinone derivativesClinical applicationsDrug-like propertiesPancreatitisPharmacological effectsRhei Radix et Rhizoma

Substanzen

AnthraquinonesDrugs, Chinese Herbal

Autor:innen und Institutionen

  • West China Center of Excellence for Pancreatitis, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Advanced Mass Spectrometry Center, Research Core Facility, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu 610213, China.
  • Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
  • State Key Laboratory of Complex, Severe, and Rare Diseases, Center for Biomarker Discovery and Validation, National Infrastructures for Translational Medicine (PUMCH), Institute of Clinical Medicine, Peking Union Medica…
  • West China Center of Excellence for Pancreatitis, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu 610041, China. Electronic address: Xiaqing@medmail.com…
  • West China Center of Excellence for Pancreatitis, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu 610041, China; Advanced Mass Spectrometry Center, Rese…

Zitieren

APA

Qiu, Q., Fu, F., Wu, Y., Han, C., Pu, W., Wen, L., Xia, Q., & Du, D. (2024). Rhei Radix et Rhizoma and its anthraquinone derivatives: Potential candidates for pancreatitis treatment. Phytomedicine. https://doi.org/10.1016/j.phymed.2024.155708

Vancouver

Qiu Q, Fu F, Wu Y, Han C, Pu W, Wen L, et al. Rhei Radix et Rhizoma and its anthraquinone derivatives: Potential candidates for pancreatitis treatment. Phytomedicine. 2024. doi:10.1016/j.phymed.2024.155708

BibTeX
@article{Qiu2024,
  author = {Qiu, Qi and Fu, Fei and Wu, Yaling and Han, Chenxia and Pu, Weiling and Wen, Li and Xia, Qing and Du, Dan},
  title = {Rhei Radix et Rhizoma and its anthraquinone derivatives: Potential candidates for pancreatitis treatment},
  journal = {Phytomedicine},
  year = {2024},
  doi = {10.1016/j.phymed.2024.155708}
}
Kostenlos starten →